Ares Financial Consulting’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.4K Buy
839
+14
+2% +$1.23K 0.05% 173
2026
Q2
$64.5K Buy
825
+45
+6% +$3.63K 0.05% 188
2026
Q1
$67.1K Hold
780
– – 0.05% 172
2025
Q4
$74.9K Buy
+780
New +$75.8K 0.07% 126

Other funds holding MDT

Ares Financial Consulting's MDT Position: Q3 2026 in Review

Ares Financial Consulting increased its Medtronic (MDT) stake by 1.7% in Q3 2026, buying an estimated $1.23K and bringing the position to 839 shares worth $72.4K. The position accounts for 0.05% of the portfolio, ranked #173.

Ares Financial Consulting first reported a position in MDT in Q4 2025 and has held it in 4 quarters since. The position peaked at $74.9K in Q4 2025. 1,271 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Ares Financial Consulting held 839 shares of Medtronic worth $72.4K as of Q3 2026.
  • Ares Financial Consulting bought 14 Medtronic shares in Q3 2026, an estimated $1.23K.
  • Medtronic made up 0.05% of Ares Financial Consulting's portfolio in Q3 2026, its #173 holding.
  • Ares Financial Consulting first reported a position in Medtronic in Q4 2025 and has held it in 4 quarters since.
  • Ares Financial Consulting's Medtronic position peaked at $74.9K in Q4 2025.
  • 1,271 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.